|
|
Spring Meeting Giovani Ricercatori
SID-SIGG-SIIA-SIMI-SIPREC-SISA 2026
Comunicazioni orali: 8+2 min
|
|
|
|
|
|
|
Domenica 19 Aprile 2026
|
|
|
|
|
14.45-16.45
|
Sessione 1 – Tecnologia e medicina: sfide e opportunità
Moderatori: Luca D’Onofrio (Roma), Francesco Spannella (Ancona)
L'impatto della tecnologia "intelligente" nella cura del diabete
• Sara Coluzzi (Pescara)
Abbiamo davvero la pressione sotto controllo? Il Ruolo dei Wearable nel monitoraggio
• Alessandro Croce (Milano)
Comunicazioni orali
Targeted plasma proteomics discriminates patients with familial hypercholesterolemia from unaffected individuals
• Stefano Scotti
Stroke at first sight: diagnosis and prognosis by a blood-based signature
• Anna Maria Ciaccio
Albumin-Corrected Anion Gap in the Prognostic Stratification of Septic Patients Admitted to Internal Medicine: a retrospective cohort study
• Tommaso Carini
A Human 3D Cardiac Microtissue Model to Investigate Aldosterone-Induced Fibrosis and Electrical Dysfunction
• Jacopo Burrello
Artificial Intelligence in Emergency Department Triage: Standard Methodology Versus Technological Innovation
• Michela Ricci
Ultrasound evaluation of carotid perivascular adipose tissue thickness as a potential marker of atherosclerosis and cardiovascular risk
• Francesco Giglioni
The role of point of care ultrasound (pocus) in ambulatorial hypertension mediated organ damage screening and detection
• Carmine De Luca
|
|
|
|
17.15-19.15
|
Sessione 2 – Nuovi paradigmi terapeutici per la protezione d’organo e la riduzione del rischio cardiovascolare
Moderatori: Ludovico Di Gioia (Acquaviva delle Fonti, Bari), Vanessa Bianconi (Perugia)
L'intelligenza dei nuovi farmaci: dalla glicemia alla protezione d'organo
• Martina Chiriacò (Pisa)
Strategie e tecnologie farmacologiche per ridurre il rischio residuo
• Andrea Baragetti (Milano)
Comunicazioni orali
GLUTREPRO: A Randomized Controlled Trial of SGLT2 Inhibitors on Renal Senescence, Inflammation, and Tubulointerstitial Injury in Chronic Kidney Disease
• Elisa Russo
The SGLT-2 inhibitor dapagliflozin rescues epicardial adipose tissue–driven cardiac progenitor cell dysfunction in human obesity via specific signaling pathways
• Carmen Tedesco
Protective effects of tirzepatide against lipotoxic stress in human cardiac progenitor cells
• Isabella Calderoni
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience
• Giosiana Bosco
Irisin as potential mediator of GLP-1 receptor agonists action
• Valerio Galasso
GLT2 inhibition improves cognitive impairment in frail older adults with HFpEF and diabetes
• Luigi Savino
A gender medicine approach to PCSK9-targeted therapy: differential response to siRNA and monoclonal antibodies
• Greta Chiarelli
|
|
|
|
|
Lunedì 20 Aprile 2026 |
|
|
|
8.30-10.30
|
Sessione 3 – Genetica ed epigenetica nelle malattie metaboliche: dal meccanismo biologico alla medicina di precisione
Moderatori: Marco Perrone (Roma), Francesco Salis (Cagliari)
Metabolismo ed epigenetica dell’invecchiamento: dai meccanismi biologici alla pratica clinica
• Luca Tagliafico (Genova)
La genetica nel metabolismo lipidico: predire gli effetti a lungo termine dei target lipidici
• Alessia Di Costanzo (Roma)
Comunicazioni orali
A Proof-of-Concept Pharmacogenetic Trial of Fenofibrate in Type 2 Diabetes: Lipids and Beyond for Cardiovascular Prevention
• Riccardo Cosma
Leukocyte telomere length in hypercholesterolemic patients: differential dynamics between clinical and genetic familial hypercholesterolemia
• Francesca Protopapa
High-parameter spectral phenotyping of platelets in Familial Chylomicronemia Syndrome
• Daniele Tramontano
Impact of Dietary Habits on Inflammatory and Metabolic Profiles and Subclinical Atherosclerosis in Patients with Familial Hypercholesterolemia
• Giovanni Pennisi
Estimation of sdLDL-cholesterol and other lipid parameters in patients with clinical suspicion of Familial Hypercholesterolemia
• Martina Ferrandino
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation
• Francesco Di Giacomo Barbagallo
Lipoprotein-bound PCSK9: structural and functional insights
• Riccardo Rizzo
|
|
|
|
16.00-18.00
|
Sessione 4 – Complicanze internistiche del paziente oncologico
Moderatori: Leonardo Bencivenga (Napoli), Rosa Curcio (Taranto)
Mismatch tra ricerca preclinica e clinica in cardio-oncologia
• Fabrizio Vallelonga (Torino)
Oltre il mismatch: la cardio-oncologia nella pratica clinica
• Mario Stabile (Bruxelles)
Modelli predittivi di tossicità nel paziente anziano oncologico candidato a terapia sistemica
• Elena Page (Genova)
Comunicazioni orali
The impact of dehydration on in-hospital, medium-term, and long-term mortality in hospitalized older adults
• Giorgia Laureti
Analysis of the Impact of Environmental Factors on Emergency Department Visits: A Longitudinal Observational Study (2014–2024)
• Marialuisa Sveva Marozzi
Comparison of prognostic risk stratification scores in patients with pulmonary embolism and active oncohematological disease presenting to the Emergency Department
• Roberto Emolo
Survivors of childhood acute lymphoblastic leukemia (ALL) present an altered immune, vascular and metabolic profile
• Marta Iaia
Unlocking the predictive power of nutritional scores in septic patients
• Noemi Maggio
|
|
|
|
|
|
Martedì 21 Aprile 2026
|
|
|
|
|
08.30-10.30
|
Sessione 5 – Nuove e vecchie sfide nella prevenzione cardiovascolare: fra avanzamento tecnologico e riscoperta della complessità biologica
Moderatori: Mario Daidone (Palermo), Damiano D’Ardes (Chieti)
Ruolo dell’AI nella diagnosi della malattia coronarica
• Stefano Benenati (Genova)
Relazioni tra fragilità e malattie cardiometaboliche
• Pasquale Mone (Campobasso)
Comunicazioni orali
The impact of NOACS versus VKAS on absolute and relative cognitive function decline over time: a machine learning approach
• Sergio Ferrantelli
Data-Driven Identification of Frailty and Resilience Phenotypes in Older Adults: Insights from a Large Comprehensive Geriatric Assessment Cohort
• Maristella Belfiori
Monocyte-to-HDL ratio and mortality risk stratification in older adults with chronic kidney disease using data-driven models
• Chiara Chinigò
Association of mitofusin 2 polymorphic variants with left ventricular hypertrophy in human hypertension
• Caroline Lopa
Extracellular vesicles isolated from patients with heart failure retain proinflammatory features
• Isabella Fichtner
ChatGPT-Based AI Workflow for Low-Cost Body Composition Estimation: Proof-of-Concept Study
• Agnese Fontana
Markers of inflammation and hypofibrinolysis are associated with cognitive dysfunction and motor performances in atrial fibrillation patients on oral anticoagulant therapy: insights from the Strat-AF Study
• Francesco Alfano
|
|
|
